123 related articles for article (PubMed ID: 8730243)
1. Gastrointestinal tolerability of lornoxicam compared to that of naproxen in healthy male volunteers.
Aabakken L; Osnes M; Frenzel W
Aliment Pharmacol Ther; 1996 Apr; 10(2):151-6. PubMed ID: 8730243
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
Bjarnason I; Macpherson A; Rotman H; Schupp J; Hayllar J
Scand J Gastroenterol; 1997 Feb; 32(2):126-30. PubMed ID: 9051872
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.
Meling TR; Aabakken L; Røseth A; Osnes M
Scand J Gastroenterol; 1996 Apr; 31(4):339-44. PubMed ID: 8726300
[TBL] [Abstract][Full Text] [Related]
5. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
Lazzaroni M; Anderloni A; Bianchi Porro G
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):833-9. PubMed ID: 11474314
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
Scheiman JM; Cryer B; Kimmey MB; Rothstein RI; Riff DS; Wolfe MM
Clin Gastroenterol Hepatol; 2004 Apr; 2(4):290-5. PubMed ID: 15067622
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS
JAMA; 1999 Nov; 282(20):1921-8. PubMed ID: 10580457
[TBL] [Abstract][Full Text] [Related]
9. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
Moberly JB; Harris SI; Riff DS; Dale JC; Breese T; McLaughlin P; Lawson J; Wan Y; Xu J; Truitt KE
Dig Dis Sci; 2007 Feb; 52(2):442-50. PubMed ID: 17216336
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
12. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
Aabakken L; Larsen S; Osnes M
Scand J Rheumatol; 1989; 18(6):361-8. PubMed ID: 2515593
[TBL] [Abstract][Full Text] [Related]
13. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers.
Aabakken L; Dybdahl JH; Eidsaunet W; Haaland A; Larsen S; Osnes M
Scand J Gastroenterol; 1989 Oct; 24(8):1007-13. PubMed ID: 2688064
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.
Goldstein JL; Jungwirthová A; David J; Spindel E; Bouchner L; Pešek F; Searle S; Skopek J; Grim J; Ulč I; Sewell KL
Aliment Pharmacol Ther; 2010 Nov; 32(9):1091-101. PubMed ID: 20804454
[TBL] [Abstract][Full Text] [Related]
15. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
Oddsson E; Gudjónsson H; Thjódleifsson B
Scand J Gastroenterol; 1992 Dec; 27(12):1045-8. PubMed ID: 1475621
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy.
Taha AS; McLaughlin S; Sturrock RD; Russell RI
Br J Rheumatol; 1989 Aug; 28(4):329-32. PubMed ID: 2525943
[TBL] [Abstract][Full Text] [Related]
17. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
Am J Gastroenterol; 1981 Jan; 75(1):17-21. PubMed ID: 7234826
[TBL] [Abstract][Full Text] [Related]
18. Low-dose antacids and nonsteroidal anti-inflammatory drug-induced gastropathy in humans.
Sievert W; Stern AI; Lambert JR; Peacock T
J Clin Gastroenterol; 1991; 13 Suppl 1():S145-8. PubMed ID: 1940189
[TBL] [Abstract][Full Text] [Related]
19. Alendronate and naproxen are synergistic for development of gastric ulcers.
Graham DY; Malaty HM
Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen.
Shah AA; Thjodleifsson B; Murray FE; Kay E; Barry M; Sigthorsson G; Gudjonsson H; Oddsson E; Price AB; Fitzgerald DJ; Bjarnason I
Gut; 2001 Mar; 48(3):339-46. PubMed ID: 11171823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
